Sustained Release Agent

Abstract Purpose: To prepare azithromycin (AZI) sustained-release suspension containing AZI-coated microcapsules (AZI-CM) impregnated with AZI-drug resin complex (AZI-DRC), in order to mask the bitter taste of AZI and improve the oral compliance of patients. Methods: The AZI-DRC was prepared…
Read More...

Abstract Hydrogels have gained attention in drug delivery systems for their ability to encapsulate nanoparticles, providing sustained and targeted release. In this study, polymeric nanoparticles (NPs) of aceclofenac (ACE) were loaded into a carbopol-based hydrogel to overcome problems associated…
Read More...

Triton™ X-100 (tert-octyl phenyl ethoxylate) is a widely and extensively used non-ionic detergent in the biopharmaceutical industry, particularly in the manufacture of biologics, plasma-derived products, and cell and gene therapies (CGTs). It is favoured due to its ability to disrupt biological…
Read More...

Abstract In situ forming implants are appealing long-acting dosage forms for both preclinical and clinical applications due to their simple manufacturing process and easy delivery. This study aims to develop extended-release in situ forming solid implants for subcutaneous administration using two…
Read More...

The healthcare sector accounts for 4.4% of the world’s net global greenhouse emissions and 8% of emissions in France. Given this situation, and at a time when sustainability is increasingly becoming a key issue, the pharmaceutical industry has no choice but to go with the flow of sustainable…
Read More...

Abstract Treating diabetic retinopathy (DR) effectively is challenging, aiming for high efficacy with minimal discomfort. While intravitreal injection is the current standard, it has several disadvantages. Implantable systems offer an alternative, less invasive, with long-lasting effects drug…
Read More...

Abstract Purpose: Effective mucosal delivery of drugs continues to pose a significant challenge owing to the formidable barrier presented by the respiratory tract mucus, which efficiently traps and clears foreign particulates. The surface characteristics of micelles dictate their ability to…
Read More...

Tamsulosin HCl is an αq-1 adrenergic receptor antagonist that is primarily used to treat benign prostatic hyperplasia (BPH), a disease defined by an enlarged prostate. The aim of this project is to develop, analyze, and compare the developed formulations to the innovator product (Flomax). The…
Read More...

Abstract The utilization of three-dimensional (3D) printing technology is prevalent in the fabrication of oral sustained release preparations; however, there is a lack of research on 3D-printed osmotic pump tablets. A 3D-printed core–shell structure bezafibrate osmotic pump tablet was developed…
Read More...

Abstract The Theophylline and Salbutamol Bilayer Sustained-release Tablets (Yi Xi Qing®), prepared via wet granulation, discolor during long-term storage, and the process is less reproducible and more cumbersome. In this study, the direct compression (DC) method was used to prepare equivalent and…
Read More...